Human Platelet Lysate is a growth factor rich supplement that maximizes mesenchymal stem cell (MSC) derived from species including mouse, human, porcine, and rabbit and enhanced its genetic stability by removing the risk of xenogeneic immune reactions and transmission of bovine prion and viral pathogens. It has been used in numerous phase I clinical trials worldwide. Human Platelet Lysate serves as an alternative to Fetal Bovine Serum (FBS) in cell and tissue culture. For example, 5% HPL in primary kidney cells used for cell growth and proliferation can be comparable to that of the culture grown in medium supplemented with10% FBS. Human Platelet Lysate derived from human donor platelets and this donor unit are pooled in large batch size which then further processed and manufacture to produce a consistent product. Heparin (Porcine)- an anticoagulant derived from the porcine intestine is used in the preparation of Human Platelet Lysate to inhibit coagulation. The US FDA is moving towards adopting European guidelines requiring that bovine materials be removed from culturing media for any therapeutic product containing cultured cells, thus making HPL an attractive alternative to the production and manufacturing processes which will fuel the demand of Human Platelet Lysate over the forecast period.
Human Platelet Lysate Market: Drivers and Restraints
Technology advancements in healthcare are now curing life-threatening diseases and giving promising results. Cell growth and proliferation have so many advantages like tissue engineering and in various other cellular therapy, this is the primary driver for this market. These supplements are useful in many immune and inflammatory disease. Increasing the prevalence rate of many diseases are driven the Human Platelet Lysate market. However, some of the restraints also are there that hamper the Human Platelet Lysate market growth such factor are increased the risk of transmission of communicable infectious diseases and the high cost of cell biology research.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/16789
Human Platelet Lysate Market: Segmentation
The global market for Human Platelet Lysate is segmented by the end user and geography:
- based on the End User, the Human Platelet Lysate market is segmented into the following:
- Academic and Research Institutes
- Biotechnology Companies
- Blood Banks
Human Platelet Lysate Market: Overview
There are various methods to prepare Human Platelet Lysate like it can be prepared by repeating freeze and thaw cycles, direct platelet activation by signification, calcium chloride or detergent. Many manufacturers are focusing on pooling as many as 50+ donors for the production of single Human Platelet Lysate batch with new techniques that offering a window to propel the growth of the Human Platelet Lysate market. Human Platelet lysate offers a true xenofree platform and has been tested in various cell culture applications including use in advanced bioreactor systems that would also boost the Human Platelet Lysate market. There is also an increasing adoption of the Human Platelet Lysate in place of FBS which is further intensifying the market.
Human Platelet Lysate Market: Region-wise Outlook
A geographic condition regarding for Human Platelet Lysate market, it has been segmented into five broad regions: North America, Latin America, Europe, APAC, and the Middle East & Africa. North America is relied upon to represent tremendous commitment under Human Platelet Lysate by income era due to increasing regulatory approvals for vaccine production via cell culture based and well-developed research centers and institutes. Stimulated advancement in old technology and high spending on imaginative work in Europe exhibits the rise of the Human Platelet Lysate market. China, India are also relied upon to show high development rate, because of increases in research centers and institutes along with encouraging the need for new techniques and methods. Furthermore, increase in government subsidizing for healthcare services are additionally anticipated that would drive development in Human Platelet Lysate market.
Human Platelet Lysate Market: Key Market Participants
Major players in the Human Platelet Lysate market include Mill Creek Life Sciences, LLC, Merck & Co., Inc, STEMCELL Technologies Inc, AventaCell BioMedical, Compass Biomedical, Inc, Macopharma SA, Trinova Biochem GmbH, PL BioScience GmbH, Cook Regentec.
To view complete report @ http://www.persistencemarketresearch.com/market-research/human-platelet-lysate-market.asp